Navigation Links
Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents, According to Scientists at the Feinstein Institute for Medical Research and Zucker Hillside Hospital
Date:10/27/2009

percent). Researchers followed these patients to understand if weight and metabolic changes are due to the new onset of a psychiatric illness or related hospital admission, or whether the observed changes are effects of the antipsychotic treatment.

The scientists found that the worsening of metabolic parameters differed between the antipsychotic medications groups, despite the shared, large and significant changes in body weight parameters, including waist circumference. Olanzapine, which was also associated with the largest effects on body weight, was associated with the greatest and most widespread worsening of lipid as well as glucose parameters. Quetiapine and risperidone were associated with varying degrees of lipid abnormalities only, which were more pronounced with quetiapine. By contrast, aripiprazole was not associated with any significant worsening in glucose or lipid parameters, which was also the case in the comparison subjects. "These findings provide further evidence for an additional, weight independent mechanism for glucose and lipid abnormalities with olanzapine that does not seem to be shared by the other antipsychotics that were studied," said Dr. Correll.

Antipsychotic medication use in young people has grown substantially in recent years and this study calls into question the effects of this upward trend. "Abnormal childhood weight and metabolic status adversely affect adult cardiovascular outcomes via continuation of these risk factors or independent or accelerated mechanisms," the scientists wrote. "Our results, together with data from first-episode studies, suggest that guidelines for antipsychotic medication exposure for vulnerable pediatric and adolescent patients naive to antipsychotic medication should consider more frequent (e.g., biannual) cardiometabolic monitoring after the first three months of treatment. Finally, in view of poor physical health outcomes and suboptimal metabolic monitor
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Antipsychotic Drugs Spur Dramatic Weight Gain in Kids
2. Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
3. FDA Panel OKs Newer Antipsychotics for Children
4. FDA Panel OKs Antipsychotic Seroquel for Children
5. FDA Panel Mulls Newer Antipsychotics for Kids
6. Joint Statement on Atypical Antipsychotic Use in Children
7. New tool to improve patient understanding of long-acting injectable antipsychotic therapies (LAT) unveiled in April issue of Psychiatry 2009
8. Newer Antipsychotics May Boost Weight in Alzheimers Patients
9. Combating weight gain caused by antipsychotic treatments
10. Newer Antipsychotics Pose Cardiac Risk: Study
11. Antipsychotics Up Death Risk in Alzheimers Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents, According to Scientists at the Feinstein Institute for Medical Research and Zucker Hillside Hospital 
(Date:9/15/2014)... York, NY (PRWEB) September 15, 2014 ... Ariana Grande concert tickets for her 2015 Honeymoon Tour. ... The 21-year-old native of Boca Raton, Florida has been active ... released her first album, which reached the top of the ... the Recording Industry Association of America for selling more than ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Today, Zane ... on Zions Bank’s Speaking on Business radio show. ... consumer product, so employers know it doesn’t make sense ... Benefits can also save the employer and employee as ... The host of Zions Bank's Speaking on Business ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Ondine ... Nicolas Loebel, its President and Chief Technology Officer, ... on Photodynamic Therapy (PDT) and Photodiagnosis in Clinical ... in Brixen/Bressanone (Italy) from October 14-18, 2014 alongside ... Medicine on October 13-14th, is an annual conference ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Transvaginal mesh ... continue to move forward in the federal multidistrict litigation ... West Virginia, Bernstein Liebhard LLP reports. According to documents ... Order on September 10th that provides for the severance ... that none of the affected plaintiffs has objected to ...
(Date:9/15/2014)... Randy Dotinga HealthDay Reporter ... Patients prescribed cholesterol-lowering drugs are more likely to fill ... are cheaper generic brands, new research suggests. At ... brands include Crestor, Zocor and Lipitor. Generic statins are ... risk of heart problems due to clogged arteries. ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Fairfax, Uncasville, Philadelphia, Orlando, San Jose, Miami, New York, Detroit, Saint Paul, Chicago, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Fairfax, Uncasville, Philadelphia, Orlando, San Jose, Miami, New York, Detroit, Saint Paul, Chicago, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3
... colonised by E. coli bacteria early in life have ... a study of infants carried out at the Sahlgrenska Academy at ... outnumber the cells in our bodies by a factor of ten ... maturation of the immune system. The normal bacterial flora in the ...
... 2012) Autism Speaks is pleased to announce the launch ... in Toddlers, or M-CHAT. The M-CHAT is a scientifically validated ... age to assess their risk for autism spectrum disorder (ASD). ... Fein, Ph.D. and clinical psychologist Marianne Barton, Ph.D. The American ...
... Scientists who found a way to make white fat behave ... new obesity treatments. Brown fat burns energy (preventing obesity), ... cells are associated with fat accumulation around organs in the ... an increased risk for diabetes and heart disease, the researchers ...
... participation in a brief training program designed to ... in how patients perceived their interactions with the ... empathy with patients usually drops during medical school ... of Massachusetts General Hospital (MGH) researchers will appear ...
... against serious pneumococcal disease does not offer full protection, ... of Gothenburg, Sweden, finding that the number of cases ... Each year an estimated 1 million children worldwide die ... those in poor countries, but pneumococcal bacteria cause disease ...
... 6, 2012) - Eye color may be an indicator of ... A study, led by the University of Colorado School of ... have vitiligo. It then follows, according to scientists, that people ... Vitiligo is an autoimmune skin disease in which pigment loss ...
Cached Medicine News:Health News:Gut flora affects maturation of B cells in infants 2Health News:Automated autism screening tool available on Autism Speaks website 2Health News:Brief training program improves resident physicians' empathy with patients 2Health News:Brief training program improves resident physicians' empathy with patients 3Health News:Pneumococcal disease: More cases but fewer deaths 2Health News:Eye color may indicate risk for serious skin conditions 2
(Date:9/15/2014)... SALT LAKE CITY , Sept. 15, 2014 ... polymer solutions to the medical device market, announced ... creation of Biomerics Advanced Catheter Division. The new division ... minimally invasive surgical device solutions for the structure ... markets. Biomerics Advanced Catheter will ...
(Date:9/15/2014)... Mass. , Sept. 15, 2014  Decision Resources ... armamentarium continues to expand, increasing pressure to control expenditures ... Interviewed payers emphasize that although type 2 diabetes drugs ... formularies are likely to enforce additional restrictions on expensive ... France , Germany , ...
(Date:9/15/2014)... LAKE CITY , Sept. 15, 2014 /PRNewswire-iReach/ ... minimally invasive surgical (MIS) visualization products, is pleased ... certification for its quality management system (QMS) through ... another important step in Olive Medical complying with ... medical devices.  It is the goal of Olive ...
Breaking Medicine Technology:Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 3Olive Medical Achieves ISO 13485:2003 Certification 2
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... financial results will be released on Friday, February 25, ... John H. Johnson, Chief Executive Officer, and David Gionco, ... an investment community conference call and webcast at 9:00 ...
... Perrigo (Nasdaq: PRGO ; TASE) today announced that ... to sell and distribute blood glucose monitors and test strips ... agreement, Perrigo will sell and distribute certain products in the ... AgaMatrix is a privately held company focused entirely on innovative ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011 2Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 2Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 3
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: